Research Articles | Page 24 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients Nov 2020 Blood Advances myelodysplastic syndromes (MDS)
Risk and timing of cardiovascular death among patients with myelodysplastic syndromes Oct 2017 Blood Advances myelodysplastic syndromes (MDS)
Venetoclax and Hypomethylating Agents (HMAs) Induce High Response Rates in MDS, Including Patients After HMA Therapy Failure Jul 2020 Blood Advances myelodysplastic syndromes (MDS)
Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse Jul 2020 Blood Advances acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients Jun 2019 Blood Advances myelodysplastic syndromes (MDS)
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide Apr 2020 Blood Advances aplastic anemia
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia Oct 2019 Blood Advances aplastic anemia
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years Oct 2019 Blood Advances aplastic anemia
Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes Sep 2017 Blood Cancer J myelodysplastic syndromes (MDS)
Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes. Feb 2017 Blood Cancer J myelodysplastic syndromes (MDS)
Share with addtoany.com.